News Search Results
Dec 04, 2025, 07:30 ET NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that following a productive discussion with Health Canada
More news about: NeuroSense
Dec 04, 2025, 07:29 ET Amity University Hosts HR Conclave 2025: Strengthening the critical link between Academia and Industry
2026.Amity University Rajasthan, Jaipur, provides students with cutting-edge laboratories for languages, media studies, education, pharmacy, biotechnology, engineering, hotel management, business management, and scientific research, as well as sophisticated facilities for a variety of research projects.The
More news about: Amity University Rajasthan
Dec 04, 2025, 07:00 ET SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Science in Commerce from the University of Virginia.About SciNeuro Pharmaceuticals SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio
More news about: SciNeuro Pharmaceuticals
Dec 04, 2025, 03:00 ET mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
The project represents a pioneering step in the application of AI to industrial biotechnology through the creation of a digital twin of the biological process, designed to enhance predictability, consistency, and efficiency in large-scale
More news about: mAbxience
Dec 04, 2025, 03:00 ET mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
The project represents a pioneering step in the application of AI to industrial biotechnology through the creation of a digital twin of the biological process, designed to enhance predictability, consistency, and efficiency in large-scale
More news about: mAbxience
Dec 03, 2025, 21:01 ET Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery
CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced the
More news about: Nona Biosciences
Dec 03, 2025, 19:05 ET Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing
CLICK HERE.Skye, headquartered in San Diego, is a clinical-stage biotechnology company developing treatments for obesity and metabolic diseases.The complaint asserts that, throughout the Class Period, Defendants failed
More news about: Berger Montague
Dec 03, 2025, 19:00 ET High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology
trial via systemic intravenous dosing under the FDA regulatory regime.About ImmViraImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization
More news about: ImmVira
Dec 03, 2025, 18:10 ET Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities.
More news about: Eisai Inc.
Dec 03, 2025, 13:53 ET Virax Biolabs Group Limited Announces $5 Million Private Placement
Dec. 3, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today that it has entered into definitive agreements for
More news about: Virax BioLabs Group Limited
Dec 03, 2025, 12:59 ET U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 03, 2025, 12:50 ET Natural Food Colors Market Set to Grow to USD 4.03 B by 2035, Creating a Global Standard-Bearer for Clean-Label Ingredients
Future Market Insights (FMI) is a leading provider of market intelligence, offering in-depth research across pharmaceuticals, healthcare, biotechnology, and life sciences. With a global research network and advanced analytical frameworks, FMI supports manufacturers, investors, policymakers, and
More news about: Future Market Insights
Dec 03, 2025, 10:30 ET Preclinical Imaging Market worth $4.39 billion by 2030 | MarketsandMarkets™
targeting.By end user, pharmaceutical & biotechnology companies are the largest end-user segment in the preclinical imaging market in 2024.the preclinical imaging market is segmented into pharmaceutical & biotechnology companies, academic & research centers, contract research
More news about: MarketsandMarkets
Dec 03, 2025, 09:23 ET Shulman Rogers Announces Elevation of Two New Shareholders
He represents startup and mature private and public companies and investors across a broad range of industries, including fintech, biotechnology, pharmaceutical, life sciences, consumer goods, retail and financial services.Clients appreciate Hunter's perspective, his diligence and
More news about: Shulman Rogers
Dec 03, 2025, 09:05 ET Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research
Gator's, we're enabling partners to rapidly bring breakthrough products to market."About Monod BioMonod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design, co-founded by Daniel Silva Manzano,
More news about: Monod Bio
Dec 03, 2025, 09:05 ET FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist Market Through 2035
Future Market Insights (FMI) is a leading provider of market intelligence, offering in-depth research across pharmaceuticals, healthcare, biotechnology, and life sciences. With a global research network and advanced analytical frameworks, FMI supports manufacturers, investors, policymakers, and
More news about: Future Market Insights, Inc.
Dec 03, 2025, 09:03 ET Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational Gonadotropin for Assisted Reproductive Technology
BOSTON, Dec. 3, 2025 /PRNewswire/ -- Granata Bio Corporation, a biotechnology company advancing innovative reproductive health solutions, announced strong momentum in its pivotal Phase III clinical study, with multiple subjects
More news about: Granata Bio
Dec 03, 2025, 09:00 ET CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens
Dec. 3, 2025 /PRNewswire/ -- At the 30th milestone edition of Food Ingredients Europe 2025, the leading Chinese biotechnology company CABIO showcases its comprehensive nutritional ingredients portfolio while simultaneously announcing the official
More news about: CABIO Biotech (Wuhan) Co, Ltd
Dec 03, 2025, 08:30 ET Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Dec 03, 2025, 08:00 ET STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced that it has been awarded a contract
More news about: STRM.BIO
Dec 03, 2025, 08:00 ET Avance Biosciences Launches Potency & Cell-Based Assay Center in Houston
testing, Avance supports clients from discovery through commercial release. Based in Houston, Texas, the company serves a global pharmaceutical and biotechnology client base.Learn more at
More news about: Avance Biosciences, Inc.
Dec 03, 2025, 07:34 ET Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Dec. 3, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, today highlighted key milestones, achievements and clinical progress
More news about: Virax BioLabs Group Limited
Dec 03, 2025, 05:04 ET Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results
clinical trial solution income represents the service income earned from our customers mainly including biopharmaceutical companies and leading biotechnology companies. We match qualified and suitable patients for enrollment in clinical trials for our customers and generate digital clinical trial solution
More news about: Waterdrop Inc.
Dec 03, 2025, 05:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Lawrence He, CEO, Rxilient.About Formosa Pharmaceuticals, Inc.Formosa Pharmaceuticals, Inc. (6838.TW) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation technology (APNT®),
More news about: Formosa Pharmaceuticals Inc.,
Dec 03, 2025, 04:01 ET CABIO Showcases Life-Stage Nutrition Innovation at Fi Europe 2025 Paris as the New Global Headquarter Opens
Dec. 3, 2025 /PRNewswire/ -- At the 30th milestone edition of Food Ingredients Europe 2025, the leading Chinese biotechnology company CABIO showcases its comprehensive nutritional ingredients portfolio while simultaneously announcing the official opening of its new Global
More news about: CABIO Biotech (Wuhan) Co, Ltd